Chunguang Xie Selected Research

qiming

2/2021	Add-on effect of Qiming granule, a Chinese patent medicine, in treating diabetic macular edema: A systematic review and meta-analysis.
10/2019	Effects of qiming granule for diabetic macular edema: A protocol for systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunguang Xie Research Topics

Disease

9	COVID-19 05/2021 - 06/2020
8	Diabetes Mellitus 04/2022 - 11/2015
6	Insulin Resistance 01/2022 - 11/2015
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2013
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Macular Edema 02/2021 - 10/2019
2	Communicable Diseases (Infectious Diseases) 09/2020 - 09/2020
2	Diabetes Complications 07/2020 - 05/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 05/2020 - 08/2019
1	Acute Lung Injury 01/2022
1	Noncommunicable Diseases 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Lung Injury 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Common Cold 05/2021
1	Obesity 01/2021
1	Coronavirus Infections 10/2020
1	Hyperglycemia 08/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2020
1	Diabetic Foot 04/2020
1	Wounds and Injuries (Trauma) 04/2020
1	Prediabetic State (Prediabetes) 03/2020
1	Diarrhea 08/2019
1	Vascular System Injuries 01/2019
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

9	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2013
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
5	Insulin (Novolin)FDA Link 05/2020 - 11/2015
4	LipidsIBA 01/2022 - 11/2015
3	shenqiIBA 04/2022 - 01/2020
3	Nonprescription Drugs (Patent Medicines)IBA 02/2021 - 10/2019
2	qimingIBA 02/2021 - 10/2019
2	NAD (NADH)IBA 05/2020 - 08/2019
1	oxidized low density lipoproteinIBA 01/2022
1	brevilin AIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Plant ExtractsIBA 05/2021
1	AntipyreticsIBA 05/2021
1	oren gedoku toIBA 01/2021
1	VaccinesIBA 10/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2020
1	Chloroquine (Aralen)FDA LinkGeneric 09/2020
1	Antiviral Agents (Antivirals)IBA 09/2020
1	qingfei paidu decoctionIBA 09/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2020
1	Angiotensin Receptor AntagonistsIBA 08/2020
1	Lian Hua Qing WenIBA 06/2020
1	danggui siniIBA 05/2020
1	Melatonin Receptors (Melatonin Receptor)IBA 05/2020
1	Hemoglobins (Hemoglobin)IBA 05/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2020
1	PrebioticsIBA 03/2020
1	Huang QiIBA 08/2019
1	ZincIBA 07/2019
1	Hormones (Hormone)IBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	CholesterolIBA 01/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2019
1	Glucagon (Glukagon)FDA Link 01/2019
1	usnic acidIBA 01/2018
1	Disopyramide (Norpace)FDA LinkGeneric 01/2018
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2018
1	Bumetanide (Bumex)FDA LinkGeneric 01/2018

Therapy/Procedure

9	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2020 - 01/2013
5	Therapeutics 01/2022 - 11/2015
1	Glycemic Control 01/2021
1	Acupuncture Therapy 08/2019
1	Acupuncture Points (Acupuncture Point) 08/2019